ADMITTING GUILT: Executives of drugmaker Par Pharmaceutical Cos. pleaded guilty Tuesday to criminal misbranding, for years of improperly marketing its weight-gain drug for frail nursing home and hospice patients vulnerable to its potentially deadly side effects.
http://washingtonexaminer.com/news-summary-nj-drugmaker-to-pay-45m-in-fines/article/feed/2077096?custom_click=rss
http://washingtonexaminer.com/news-summary-nj-drugmaker-to-pay-45m-in-fines/article/feed/2077096?custom_click=rss
No comments:
Post a Comment